Danaher Corp
Close on Oct 30, 2026Market cap $163.25BP/E 41.2Yield –
Danaher ClinicalTrials.gov — Lead-Sponsor Trials Started by Year
Danaher ClinicalTrials.gov — Lead-Sponsor Trials Started: 13 in FY2025, up 18.2% from a year earlier.
Where the FY2025 figure comes from
Source: NIH ClinicalTrials.gov API v2 (Lead-Sponsor Study Registry) ↗
A total of 166 cumulative clinical trials on ClinicalTrials.gov lead-sponsored by Danaher operating companies.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | ClinicalTrials.gov — Lead-Sponsor Trials Started | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 13 | +18.2% | NIH ClinicalTrials.gov API v2 (Lead-Sponsor Study Registry) ↗ |
| FY2024 | Dec 31, 2024 | 11 | -42.1% | NIH ClinicalTrials.gov API v2 (Lead-Sponsor Study Registry) ↗ |
| FY2023 | Dec 31, 2023 | 19 | +72.7% | NIH ClinicalTrials.gov API v2 (Lead-Sponsor Study Registry) ↗ |
| FY2022 | Dec 31, 2022 | 11 | +57.1% | NIH ClinicalTrials.gov API v2 (Lead-Sponsor Study Registry) ↗ |
| FY2021 | Dec 31, 2021 | 7 | 0.0% | NIH ClinicalTrials.gov API v2 (Lead-Sponsor Study Registry) ↗ |
| FY2020 | Dec 31, 2020 | 7 | -58.8% | NIH ClinicalTrials.gov API v2 (Lead-Sponsor Study Registry) ↗ |
| FY2019 | Dec 31, 2019 | 17 | -10.5% | NIH ClinicalTrials.gov API v2 (Lead-Sponsor Study Registry) ↗ |
| FY2018 | Dec 31, 2018 | 19 | +58.3% | NIH ClinicalTrials.gov API v2 (Lead-Sponsor Study Registry) ↗ |
| FY2017 | Dec 31, 2017 | 12 | -36.8% | NIH ClinicalTrials.gov API v2 (Lead-Sponsor Study Registry) ↗ |
| FY2016 | Dec 31, 2016 | 19 | – | NIH ClinicalTrials.gov API v2 (Lead-Sponsor Study Registry) ↗ |
Breakdown
What makes up clinicalTrials.gov — Lead-Sponsor Trials Started
- ClinicalTrials.gov — Target/Actual Enrollment8,271 · FY2025
- Cepheid — Clinical Trials Started During the Year (cumulative total of 10 studies)3 · FY2025
- Beckman Coulter — Clinical Trials Started During the Year (cumulative total of 31 studies)1 · FY2025
- Leica Biosystems — Clinical Trials Started During the Year (cumulative total of 0 studies)0 · FY2025
- Radiometer Medical — Clinical Trials Started During the Year (cumulative total of 19 studies)6 · FY2025
- Devicor Medical / Mammotome — Clinical Trials Started During the Year (cumulative total of 1 study)0 · FY2025
- Masimo Corporation — Clinical Trials Started During the Year (cumulative total of 105 studies)3 · FY2025
Cite this data
StockData. (2026). Danaher ClinicalTrials.gov — Lead-Sponsor Trials Started, annual FY2016–FY2025 [Data set]. Compiled from Danaher SEC filings and investor materials. https://stockdatahq.com/stocks/dhr/kpis/ext-ct-studies-dhr-total
See every metric in the Danaher KPI table. Data updated Nov 2, 2026.